Search Results | Chinese Journal of Pharmacoepidemiology

Home Results

A total of 8 result was found. Results that relate to Cost-utility analysis

黄葵胶囊对比氯沙坦钾片治疗IgA肾病的药物经济学评价

Liang-Wen GOU Zhao-Ting GUO Qiong LUO Nan YANG Ming HU

DOI：10.19960/j.issn.1005-0698.202301001

Huangkui capsule Losartan potassium tablets Chronic kidney disease Pharmacoeconomics Cost-utility analysis
Details Download Mobile
参苓白术散治疗老年男性肌少症的成本-效用分析

Huan-Huan JIANG Hui-Qin SHEN Zhi-Xiu WANG Yun-Fei CHEN Hui GUO Na XU

DOI：10.19960/j.issn.1005-0698.202304003

Shenling Baizhu powder Sarcopenia Cost-utility analysis Pharmacoeco-nomics
Details Download Mobile
沙库巴曲缬沙坦、达格列净和恩格列净治疗射血分数降低心力衰竭的成本-效用分析

Dan-Dan LU Sheng-Xiang WANG Shan LU Dan PAN Li-Yuan SHI Fei-Chuang Jing2

DOI：10.19960/j.issn.1005-0698.202308006

Heart failure with reduced ejection fraction Sacubitril/valsartan Dapagliflozin Empagliflozin Markov model Cost-utility analysis
Details Download Mobile
布地奈德福莫特罗粉吸入剂与沙美特罗替卡松粉吸入剂治疗青少年哮喘的成本-效用分析

SHEN Anle WU Bin LIU Dan JIANG Yuelian WU Juan YIN Yong ZHANG Shunguo

DOI：10.12173/j.issn.1005-0698.202312072

Budesonide/formoterol Salmeterol/fluticasone Cost-utility analysis Asthma Adolescent
Details Download Mobile
阿扎胞苷与地西他滨治疗骨髓增生异常综合征的成本-效用分析

La-Ji DANZENG Yong-Gong YANG Si-Liang WANG Meng-Ying LIU

DOI：10.19960/j.issn.1005-0698.202312007

Azacitidine Decitabine Myelodysplastic syndrome Markov model Cost-utility analysis Pharmacoeconomics
Details Download Mobile
依达拉奉右莰醇治疗急性缺血性脑卒中的成本-效用分析

ZHOU Shasha CHEN Xiangfan CHEN Xia

DOI：10.12173/j.issn.1005-0698.202305025

Edaravone dexborneol Edaravone Acute ischemic stroke Decision tree model Cost-utility analysis
Details Download Mobile
氟替美维吸入粉雾剂治疗慢性阻塞性肺疾病的药物经济学评价

DING Xueru LIU Huimin HE Xiaodong LI Hua LI Zhihao

DOI：10.12173/j.issn.1005-0698.202404016

Fluticasone furoate/umeclidinium/vilanterol Chronic obstructive pulmonary disease Markov model Cost-utility analysis Pharmacoeconomic
Details Download Mobile
帕博利珠单抗联合化疗治疗晚期恶性胸膜间皮瘤的成本-效用分析

HU Yunjia ZOU Keqing HOU Yanhong

DOI：10.12173/j.issn.1005-0698.202407011

Pembrolizumab Chemotherapy Advanced malignant pleural mesothelioma Partitioned survival model Cost-utility analysis Pharmacoeconomic evaluation
Details Download Mobile